Compounds > sertraline
Page last updated: 2024-08-24

sertraline and Liver Neoplasms

sertraline has been researched along with Liver Neoplasms in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's2 (33.33)24.3611
2020's2 (33.33)2.80

Authors

AuthorsStudies
Kamoi, S; Kozawa, O; Matsushima-Nishiwaki, R1
Akkari, L; Beijersbergen, RL; Benedict, B; Bernards, R; de Oliveira, RL; du Chatinier, A; Evers, B; Gadiot, J; Gao, D; Jin, G; Jin, H; Jochems, F; Lieftink, C; Mainardi, S; Morris, B; Qin, W; Ramirez, C; Sanchez, AM; Schepers, A; Te Riele, H; Vegna, S; Wang, C; Wang, L; Wang, W; Xue, Z1
Bi, F; Tang, Q; Xu, H; Zhang, H1
Egashira, N; Kuwahara, J; Masuda, S; Ueda, M; Ushio, S; Yamada, T; Zukeyama, N1
Abadie-Lacourtoisie, S; Lortholary, A; Morand, C; Paillocher, N; Petit, S1
Noyer, CM; Schwartz, BM1

Other Studies

6 other study(ies) available for sertraline and Liver Neoplasms

ArticleYear
Upregulation by duloxetine of the transforming growth factor-α-induced migration of hepatocellular carcinoma cells via enhancement of the c-Jun N-terminal kinase activity.
    Cell biochemistry and function, 2023, Volume: 41, Issue:7

    Topics: Carcinoma, Hepatocellular; Duloxetine Hydrochloride; Fluvoxamine; Humans; JNK Mitogen-Activated Protein Kinases; Liver Neoplasms; Norepinephrine; p38 Mitogen-Activated Protein Kinases; Phosphorylation; Proto-Oncogene Proteins c-akt; Serotonin; Sertraline; Transforming Growth Factor alpha; Up-Regulation

2023
Inducing and exploiting vulnerabilities for the treatment of liver cancer.
    Nature, 2019, Volume: 574, Issue:7777

    Topics: Animals; Apoptosis; Cell Cycle Proteins; Cell Line, Tumor; Cellular Senescence; Disease Models, Animal; Female; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Molecular Targeted Therapy; Mutation; Protein Serine-Threonine Kinases; Sertraline; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Suppressor Protein p53

2019
The selective serotonin reuptake inhibitors enhance the cytotoxicity of sorafenib in hepatocellular carcinoma cells.
    Anti-cancer drugs, 2021, 09-01, Volume: 32, Issue:8

    Topics: Animals; Carcinoma, Hepatocellular; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Combinations; Floxuridine; Humans; Liver Neoplasms; Male; Mice; Mice, Inbred BALB C; Proto-Oncogene Proteins c-akt; Selective Serotonin Reuptake Inhibitors; Sertraline; Sorafenib; TOR Serine-Threonine Kinases; Xenograft Model Antitumor Assays

2021
Comparison of the Anti-tumor Effects of Selective Serotonin Reuptake Inhibitors as Well as Serotonin and Norepinephrine Reuptake Inhibitors in Human Hepatocellular Carcinoma Cells.
    Biological & pharmaceutical bulletin, 2015, Volume: 38, Issue:9

    Topics: Antineoplastic Agents; Carcinoma, Hepatocellular; Caspase 3; Caspase 7; Cell Line, Tumor; Cell Survival; Citalopram; Cyclopropanes; Duloxetine Hydrochloride; Fluvoxamine; Hep G2 Cells; Humans; Liver Neoplasms; Milnacipran; Paroxetine; Selective Serotonin Reuptake Inhibitors; Serotonin and Noradrenaline Reuptake Inhibitors; Sertraline

2015
[Isolated increase in alkaline phosphatase following ingestion of sertraline].
    Presse medicale (Paris, France : 1983), 2004, Sep-11, Volume: 33, Issue:15

    Topics: Adult; Alkaline Phosphatase; Antidepressive Agents; Bone Neoplasms; Breast Neoplasms; Female; Humans; Liver; Liver Neoplasms; Sertraline

2004
Sertraline, a selective serotonin reuptake inhibitor, unmasking carcinoid syndrome.
    The American journal of gastroenterology, 1997, Volume: 92, Issue:8

    Topics: 1-Naphthylamine; Carcinoid Tumor; Depression; Female; Humans; Liver Neoplasms; Middle Aged; Selective Serotonin Reuptake Inhibitors; Sertraline

1997